Related Experiment Video

Updated: May 16, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

Scutellarin-induced apoptosis in HepG2 hepatocellular carcinoma cells via a STAT3 pathway

Haitao Xu1, Songyan Zhang

  • 1Department of Hepatopancreatobiliary Surgery, The Third Affiliated Hospital of Harbin Medical University, Harbin, 150086, P.R., China.

Phytotherapy Research : PTR
|November 30, 2012
PubMed

Insights

Scutellarin effectively inhibits liver cancer cell growth and induces apoptosis in HepG2 cells. This natural compound works by downregulating the STAT3 signaling pathway, offering potential as a novel liver cancer treatment.

Area of Science:

  • Oncology
  • Pharmacology
  • Biochemistry

Background:

  • Liver cancer is a leading cause of cancer mortality with limited effective treatments.
  • Scutellarin, a compound from medicinal plants, is being investigated for its therapeutic potential.

Purpose of the Study:

  • To investigate the inhibitory effects of Scutellarin on HepG2 hepatocellular carcinoma cells.
  • To explore the underlying molecular mechanisms of Scutellarin's action.

Main Methods:

  • MTT assay to assess cell proliferation.
  • Staining assays to detect apoptosis.
  • Western blot analysis to examine protein expression, including STAT3 and its targets.

Main Results:

  • Scutellarin significantly inhibited HepG2 cell proliferation in a dose- and time-dependent manner.
  • Scutellarin induced typical apoptotic features and reduced reactive oxygen species (ROS) production.
  • Scutellarin downregulated STAT3 protein expression and its downstream targets, Bcl-XL and Mcl-1.

Conclusions:

  • Scutellarin inhibits proliferation and induces apoptosis in HepG2 cells through the STAT3 signaling pathway.
  • These findings support Scutellarin's potential as an alternative therapeutic agent for liver cancer.
Keywords:
Mcl-1STAT3Scutellarinapoptosishepatocellular carcinoma

More Related Videos

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death09:18

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death

Published on: December 27, 2016

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...